Delivery Order SPE2DB22D1106-SPE2DB25FFBQ0
- Not listed
- The Defense Logistics Agency awarded a $26,366 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This non-set-aside contract is classified as a delivery order with an ultimate completion date of August 1, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively selected to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in syringe form (0.5mL) with a ceiling value of $1,064.40. This competitively awarded, firm fixed-price delivery order was issued on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract utilizes no set-aside designation and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a $9,491.76 delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine syringes (0.5ML) on July 30, 2025, with completion targeted for July 31, 2025. This firm fixed-price contract represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,641.31 to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5ML syringes. This firm fixed-price, competitively awarded contract was executed on July 28, 2025, with an ultimate completion date of July 29, 2025. The vaccine will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $39,915.00 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Boostrix TDAP vaccine syringes (0.5mL). This firm fixed price delivery order, with an ultimate completion date of July 21, 2025, represents performance at the contractor's Conshohocken, Pennsylvania facility. The award was not designated as a set-aside contract and was competitively awarded to the prime contractor. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $36,721.80 to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This competitively awarded, firm fixed-price delivery order was executed on August 4, 2025, with an ultimate completion date of August 5, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen Drug Corp's existing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Boostrix TDAP vaccine in 0.5 mL syringes. This competitively awarded, non-set-aside contract carries a ceiling value of $4,470.50 and is structured as a firm fixed price delivery order with an ultimate completion date of August 1, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains operations as...
- The Defense Logistics Agency awarded a delivery order valued at $9,491.76 to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5 mL syringes. The contract is a firm fixed price delivery order with an ultimate completion date of July 21, 2025, and represents a competitively awarded, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,862.70 to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5mL syringe format, with a completion date of July 24, 2025. This non-set-aside, firm fixed price delivery order represents a competitively awarded procurement executed on July 23, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $2,694.75 delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine syringes (0.5ML) on July 24, 2025, with an ultimate completion date of July 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The place of performance is...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFBQ0Delivery Order
The Defense Logistics Agency awarded a $1,306.15 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5mL syringe format, with an ultimate completion date of August 6, 2025. This non-set-aside contract was awarded on August 5, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, was competitively selected to fulfill this requirement through an open procurement process. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. This prime IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including vaccines, medications, syringes, and medical devices across multiple therapeutic domains. The contract serves critical customers including the Defense Health Agency and U.S. Coast Guard, demonstrating AmerisourceBergen Drug Corp's established capability to meet federal medical supply requirements at scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/5/25 |